Literature DB >> 20518949

Coronary heart disease risk assessment in HIV-infected patients: a comparison of Framingham, PROCAM and SCORE risk assessment functions.

M M Moreira Guimarães1, D Bartolomeu Greco, A H Ingles Garces, A R de Oliveira, R Bastos Fóscolo, L J de Campos Machado.   

Abstract

OBJECTIVES: The aim of this was to compare the performance of the Framingham, Systematic Coronary Risk Evaluation (SCORE) and Prospective Cardiovascular Munster (PROCAM) scoring systems in the risk assessment of HIV-infected patients with no overt vascular disease.
METHODS: A cross-sectional study of 220 HIV-infected patients was conducted at the outpatient clinic of a referral and training centre in infectious and parasitic diseases in Belo Horizonte, Brazil. The Framingham, SCORE and PROCAM equations were calculated. Patients were classified as having low, moderate or high risk, which according to the Framingham and PROCAM equations corresponded to < 10%, 10-20% and > 20% respectively, and according to SCORE corresponded to < 3%, 3-4% and > or = 5% respectively. Cohen's kappa coefficient was used to assess agreement between the methods.
RESULTS: Of a total of 220 HIV-infected patients, 56 were antiretroviral (ARV)-naïve while 164 had already been treated with ARV. The prevalence of patients with a high 10-year cardiovascular risk was 3.7%, 2.5% and 1.9% according to the Framingham, PROCAM and SCORE equations respectively. The degree of agreement was moderate between the Framingham and PROCAM risk estimates (kappa = 0.433; p < 0.001), poor-to-fair between the Framingham and SCORE estimates (kappa = 0.220; p < 0.001) and moderate between the PROCAM and SCORE systems (kappa = 0.478; p < 0.001).
CONCLUSIONS: There are differences in risk assessment and in the identification of high risk individuals between the three risk functions under evaluation and only a prospective study will be capable of assessing which offers the best current sensitivity, specificity and predictive values for the population under investigation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20518949     DOI: 10.1111/j.1742-1241.2009.02248.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  13 in total

Review 1.  Noninvasive assessment of HIV-related coronary artery disease.

Authors:  Louis H Miller; John T Coppola
Journal:  Curr HIV/AIDS Rep       Date:  2011-06       Impact factor: 5.071

2.  Differences by HIV serostatus in coronary artery disease severity and likelihood of percutaneous coronary intervention following stress testing.

Authors:  Matthew J Feinstein; Brian Poole; Pedro Engel Gonzalez; Anna E Pawlowski; Daniel Schneider; Tim S Provias; Frank J Palella; Chad J Achenbach; Donald M Lloyd-Jones
Journal:  J Nucl Cardiol       Date:  2016-10-13       Impact factor: 5.952

3.  Assessing and Refining Myocardial Infarction Risk Estimation Among Patients With Human Immunodeficiency Virus: A Study by the Centers for AIDS Research Network of Integrated Clinical Systems.

Authors:  Matthew J Feinstein; Robin M Nance; Daniel R Drozd; Hongyan Ning; Joseph A Delaney; Susan R Heckbert; Matthew J Budoff; William C Mathews; Mari M Kitahata; Michael S Saag; Joseph J Eron; Richard D Moore; Chad J Achenbach; Donald M Lloyd-Jones; Heidi M Crane
Journal:  JAMA Cardiol       Date:  2017-02-01       Impact factor: 14.676

4.  Taming HIV-related inflammation with physical activity: a matter of timing.

Authors:  Gabriella d'Ettorre; Giancarlo Ceccarelli; Noemi Giustini; Claudio M Mastroianni; Guido Silvestri; Vincenzo Vullo
Journal:  AIDS Res Hum Retroviruses       Date:  2014-09-17       Impact factor: 2.205

Review 5.  Cardiovascular disease risk in an aging HIV population: not just a question of biology.

Authors:  Kaku So-Armah; Matthew S Freiberg
Journal:  Curr Opin HIV AIDS       Date:  2014-07       Impact factor: 4.283

Review 6.  Cardiovascular risk estimation in 2012: lessons learned and applicability to the HIV population.

Authors:  Ralph B D'Agostino
Journal:  J Infect Dis       Date:  2012-06       Impact factor: 5.226

7.  Prevalence of traditional cardiovascular risk factors and evaluation of cardiovascular risk using three risk equations in nigerians living with human immunodeficiency virus.

Authors:  Ayodele Olugbenga Edward; Akinboro Adeolu Oladayo; Akinyemi Suliat Omolola; Adepeju Akinlawon Adetiloye; Popoola Adetoun Adedayo
Journal:  N Am J Med Sci       Date:  2013-12

8.  Mind the gap: difference between Framingham heart age and real age increases with age in HIV-positive individuals-a clinical cohort study.

Authors:  Teri-Louise Davies; Mark Gompels; Sarah Johnston; Begoña Bovill; Margaret T May
Journal:  BMJ Open       Date:  2013-10-25       Impact factor: 2.692

9.  Cardiovascular risk assessment: a comparison of the Framingham, PROCAM, and DAD equations in HIV-infected persons.

Authors:  Max Weyler Nery; Celina Maria Turchi Martelli; Erika Aparecida Silveira; Clarissa Alencar de Sousa; Marianne de Oliveira Falco; Aline de Cássia Oliveira de Castro; Jorge Tannus Esper; Luis Carlos Silva e Souza; Marília Dalva Turchi
Journal:  ScientificWorldJournal       Date:  2013-10-21

10.  Risk of coronary heart disease among HIV-infected patients: a multicenter study in Brazil.

Authors:  Sandra C Fuchs; Paulo R Alencastro; Maria Letícia R Ikeda; Nêmora T Barcellos; Fernando H Wolff; Ajácio B M Brandão; Ricardo A A Ximenes; Demócrito de B Miranda-Filho; Heloísa Ramos Lacerda; Maria de Fátima P M de Albuquerque; Ulisses Ramos Montarroyos; Max W Nery; Marilia D Turchi
Journal:  ScientificWorldJournal       Date:  2013-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.